In much the same way, in our present study, multi-agonists magnified anti-neuroinflammatory and neuroprotective benefits as compared to a single GLP-1R agonist in cell culture models of neurodegenerative disease. This evidence concerns the gene GLP1R and neurodegenerative disease.